A federal judge in Texas on Monday dismissed a drug industry trade group’s legal challenge to halt Medicare drug price negotiations, ruling it lacked standing. Why it matters: It’s the first time a court has thrown out a lawsuit to overturn the talks required by the Inflation Reduction Act, which began earlier this month.